Interferon Omega-1 (IFNW1) Antibody (FITC)
169€ (20 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Interferon Omega-1 (IFNW1) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx300546
Description
IFNW1 Antibody (FITC) is a Rabbit Polyclonal against IFNW1 conjugated to FITC.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Interferon Omega-1 (IFNW1) |
| Host | Rabbit |
| Reactivity | Cow |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | FITC |
| Isotype | IgG |
| Purity | > 95% |
| Purification | Purified by Protein G. |
| Size 1 | 20 µg |
| Size 2 | 50 µg |
| Size 3 | 100 µg |
| Size 4 | 200 µg |
| Size 5 | 1 mg |
| Form | Liquid |
| Buffer | 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P07352 |
| Gene ID | 281847 |
| Alias | Interferon alpha-II-1 |
| Background | Antibody anti-IFNW1 |
| Status | RUO |
Descripción
Interferon Omega 1 (IFNW1) is a type I interferon that belongs to the family of interferons known for their critical roles in antiviral defense, immune regulation, and cell growth inhibition. IFNW1 is predominantly produced by leukocytes in response to viral infections and other immune stimuli. This cytokine binds to the type I interferon receptor (IFNAR), initiating a signaling cascade through the JAK-STAT pathway. This activation leads to the transcription of interferon-stimulated genes (ISGs), which encode proteins that inhibit viral replication, enhance antigen presentation, and activate immune cells such as natural killer cells and macrophages. IFNW1 has a similar but distinct activity profile compared to other type I interferons, such as IFN-alpha and IFN-beta, with potential applications in treating viral infections and certain malignancies. It is being explored in therapeutic contexts, including its use as an immunomodulatory agent in chronic viral infections and autoimmune disorders. Elevated levels of IFNW1 are associated with heightened immune activity, and its therapeutic modulation could provide benefits in diseases with dysregulated immune responses.
Related Products
Human IFNW1 (Interferon omega-1) ELISA Kit
Ver Producto
Recombinant Human IFNW1
Ver Producto
Interferon Omega-1 (IFNW1) Antibody
IFNW1 Antibody is a Rabbit Polyclonal Antibody against IFNW1.
Ver Producto